Muenchener Rueckver (MUV2.DE) traded up 0.14 % during a 24 hours period ending at 10:17 AM Central Europe on Tuesday 27th. One Muenchener Rueckver stock can currently be bought for about EUR 555.3 on popular exchanges. Current supply of Muenchener Rueckver stocks is 125.8 mn. Muenchener Rueckver has a current market capitalization of EUR 70.3 bn and approximately EUR 107.5 mn worth of Muenchener Rueckver was traded on exchanges in the last 24 hours. Since last month end, Muenchener Rueckver has traded 8.44 % up. Simple moving average of last 200 days is at EUR 513.98. The highest price of past 52 weeks was recorded at EUR 572.6 on 04/21/2026. 52 weeks low was at EUR 437.4 on 06/02/2026.
Summary of the latest news for Muenchener Rueckver
Münchener Rückversicherungs‑Gesellschaft, commonly referred to as Münchener Rück, continues to maintain a stable position within the Euro STOXX 50 index. Recent market activity shows the company trading near the mid‑range of its peers, with only modest fluctuations in its share price. Analysts note that the insurer’s valuation remains largely in line with industry expectations, and its performance has not deviated significantly from the broader index trend. Market commentary highlights that while the broader German market has experienced some volatility, Münchener Rück’s share price movements have been relatively restrained, reflecting its long‑term risk‑management strategy and diversified underwriting portfolio. The company’s stability is viewed as a potential anchor in an environment where other European insurers have exhibited more pronounced swings.
Here is how related stocks have performed in the past 24 hours:
Bayer (BAYN.DE) traded up 3.59 % and now trades at EUR 45.22. Current market capitalisation for Bayer is EUR 44.7 bn. Bayer AG’s recent developments have attracted market attention. In Ohio, the company is investing in a new pharmaceutical facility, signalling continued focus on expanding its manufacturing footprint. Clinical progress for key products also underpins investor interest. A post‑hoc analysis of patient‑reported sleep outcomes for Lynkuet® (elinzanetant) in women with moderate‑to‑severe vasomotor symptoms was presented at the 2026 Menopause Society Annual Meeting, adding to the company’s portfolio of treatments for menopausal symptoms. Meanwhile, a Phase‑III study of the prostate‑cancer drug Nubeqa reported a significant reduction in metastasis and mortality risk, providing a potential new growth driver for the company’s oncology division. These combined investment and clinical updates contribute to a cautiously positive outlook for Bayer’s future performance.
Rheinmetall (RHM.DE) traded up 1.49 % and now trades at EUR 1,023.8. Rheinmetall has a market capitalisation of EUR 48.3 bn. Rheinmetall has a current price to earnings ratio of 39.67. Rheinmetall AG experienced a modest rally in early trading after a recent recovery from a sharp decline, with the share price hovering near its 50‑day moving average. Analysts note that the stock is still largely sideways, and that a further upward move will depend on the company’s ability to secure new defence contracts and maintain momentum from recent orders. Recent coverage highlights Rheinmetall’s involvement in a large Italian programme for military vehicles, which has attracted attention from both the company and its partner Leonardo. The deal could strengthen Rheinmetall’s production base, but the company’s stock remains sensitive to broader market sentiment and to the pace of defence spending in Europe. Meanwhile, the market has taken a cautious stance towards the company’s valuation, reflecting uncertainty about the speed at which new contracts will materialise. The share price is currently stabilising around the €1,000 level, with analysts monitoring further price action in light of upcoming central‑bank meetings and global economic developments.
Siemens Healthineers (SHL.DE) traded up 1.03 % and now trades at EUR 42.2. Current market capitalisation for Siemens Healthineers is EUR 46.8 bn. Current price/earnings ratio for Siemens Healthineers is 21.33. Siemens Healthineers AG has issued a capital‑market information notice under the EU regulation on post‑admission duties. The company disclosed that it has been buying back its own shares in a structured buy‑back program that began in early June. Between 19 and 25 October, 50 000 shares were repurchased each day, with the average price gradually rising over that week. The cumulative volume bought back since the program’s launch totals more than three and a half million shares. All transactions were conducted through a commissioned credit institution on the XETRA platform. The notice also provides a link to the company’s investor relations site where full details of the buy‑back are published. No further operational or financial commentary was included.
Deutsche Boerse (DB1.DE) traded up 0.06 % and now trades at EUR 314.7. Deutsche Boerse has a market capitalisation of EUR 56.4 bn. Deutsche Boerse has a current price to earnings ratio of 25.86.
Dhl AG (DHL.F) traded up 3.39 % and now trades at EUR 58.43. Dhl AG has a market capitalisation of EUR 65 bn. Current price/earnings ratio for Dhl AG is 17.86. DHL AG has announced a share‑buyback programme, purchasing a total of 93,920 shares between 19 and 23 October 2026. The repurchases were conducted on several European trading venues, with an average purchase price around fifty‑seven euros per share. The company has also reported that, as of 23 October, it has bought back more than three million shares since the start of the programme on 10 August 2026. The announcement was made through the mandatory post‑admission duties system, with the issuer confirming the details. No offer or solicitation of shares was implied by the disclosure. The company’s investor relations contact was provided for further inquiries.
About Muenchener Rueckver
The MunichRe is a financial service provider with its main operations in Munich, Germany. The company offers reinsurance, insurance, and asset management services. It has subsidiaries in most significant financial centers globally.
